Merck has announced that 15 new positions have been created at its Livingston facility as part of a £2.6m investment.
This is a result of a request made to the science and technology company to tender for the design, development and commercialisation of a novel diagnostic quality control kit for blood typing analysers.
Supported by a research and development grant from Scottish Enterprise, Merck was successfully selected as the project partner. The new product range has now been validated and has received regulatory approval in several key geographies, allowing it to be launched globally during April.
